Comparison of 4- and 24-hour intravenous infusion schedules for granulocyte-macrophage colony-stimulating factor.
Wong
L
L
Arizona Cancer Center, Tucson 85724, USA.
Taylor
C W
CW
Radwanski
E
E
Hersh
E M
EM
Salmon
S E
SE
D000328:Adult; D000368:Aged; D004334:Drug Administration Schedule; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics
D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor